Massachusetts General Hospital — Clinical Trial Pipeline

Massachusetts General Hospital has 12 registered trials in the index.

Trials (12)

• Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases N/A · Massachusetts General Hospital
• Supportive Oncology Care At Home RCT N/A · Massachusetts General Hospital
• The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients N/A · Massachusetts General Hospital
• Phase I Study of Sequential Cord Blood Transplants Phase 1 · Massachusetts General Hospital
• Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy N/A · Massachusetts General Hospital
• Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer N/A · Massachusetts General Hospital
• Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation Phase 2 · Massachusetts General Hospital
• Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors Phase 1 · Massachusetts General Hospital
• Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma N/A · Massachusetts General Hospital
• Polycystic Ovary Syndrome Genetics and Treatment Response N/A · Massachusetts General Hospital
• Mind-Body Sexual Well-Being Program for Female GI Cancer Survivors N/A · Massachusetts General Hospital
• Fulvestrant + Neratinib In Breast Cancer Phase 2 · Massachusetts General Hospital

Related landscapes

• Lymphoma
• Myelodysplastic Syndrome
• Hepatocellular Cancer
• Cholangiocarcinoma
• Hepatic Metastases

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.